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Abstract
Background: Antibiotics are highly utilized in nursing homes. The aim of the study was to test the effectiveness of
a decision-making aid for urinary tract infection management on reducing antibiotic prescriptions for suspected
bacteriuria in the urine without symptoms, known as asymptomatic bacteriuria (ASB) in twelve nursing homes in
Texas.
Method: A pre- and post-test with comparison group design was used. The data was collected through
retrospective chart review. The study sample included 669 antibiotic prescriptions for suspected urinary tract
infections ordered for 547 nursing home residents. The main measurement for the outcome variable was whether
an antibiotic was prescribed for suspected urinary tract infections with no symptoms present.
Results: Most of the prescriptions for antibiotics UTIs were written without documented symptoms – thus for
asymptomatic bacteuria (ASB) (71 % during the pre-intervention period). Exposure to the decision-making aid
decreased the number of prescriptions written for ASB (from 78 % to 65 % in the low-intensity homes and from
65 % to 57 % in the high-intensity homes), and decreased odds of a prescription being written for ASB (OR = 0.63,
95 % CI = 0.25 – 1.60 for low-intensity homes; OR = 0.79, 95 % CI = 0.33 – 1.88 for high-intensity homes). The odds
of a prescription being written for ASB decreased significantly in homes that succeeded in implementing the
decision-making aid (OR = 0.35, 95 % CI = 0.16–0.76), compared to homes with no fidelity.
Conclusions: The decision-making aid improved antibiotic stewardship in nursing homes.
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Background
Antibiotics are highly utilized in nursing homes. Up to
70 percent of nursing home residents may receive at
least one antimicrobial agent a year [1, 2]. Similarly, [3]
found that 47 % to 79 % of the nursing home residents
receive at least on course of antibiotics per year [3].
High rates of antibiotic use make nursing homes a
breeding ground for antibiotic-resistant bacteria, from
Methicillin-resistant Staphylococcus aureus (MRSA) to
resistant Clostridium difficile infections (CDI) [4, 5]. The
emergence of multidrug resistant organisms in nursing
homes and consequent spread to the community
combined with other negative outcomes of antibiotic
overuse, such as adverse drug events, hospital admis-
sions, and higher health care costs, calls for optimizing
antibiotic stewardship in nursing homes [4].
One avenue for reducing the overall rate of antibiotic
prescriptions is to reduce the number of “inappropriate”
antibiotic prescriptions. However, determining “appro-
priateness” of antibiotic use in nursing homes is challen-
ging. In the nursing home setting antibiotic courses are
often started empirically due to the limited availability of
diagnostics. Even so, the general consensus is that in-
appropriate antibiotic use occurs frequently in nursing
homes. Examples of potentially inappropriate practices
in nursing homes include prescribing antibiotics as a
prophylaxis, prescribing without a clear description of
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the source of the infection, and in the case of urinary
tract infections (UTIs), prescribing antibiotics in the ab-
sence of specific symptoms indicating the presence of a
UTI [6, 7]. Urinary tract infections are the most com-
mon nursing home infection, making proper treatment
essential to nursing home quality of care [8, 9]. Up to
one-third of prescriptions for suspected urinary tract in-
fections in nursing home residents are for asymptomatic
patients with bacteriuria (bacteria in the urine) [2]. This
practice of prescribing antibiotics for bacteriuria in the
absence of outward symptoms is possibly influenced by
abnormal urinalyses rather than physical symptoms [10].
Bacteriuria without symptoms, known as asymptomatic
bacteriuria (ASB), is common in nursing home residents,
with prevalence as high as 50 percent – and is often re-
lated to changes in the functionality of the bladder and
urinary tract associated with aging and comorbid condi-
tions [11, 12]. There are consistent findings indicating
that treating residents for bacteriuria without symptoms
is not beneficial, and possibly harmful [13, 14]. The po-
tential for large numbers of unnecessary antibiotic pre-
scriptions in nursing homes makes this setting ideal for
implementing an intervention aimed at reducing anti-
biotic use for ASB and reducing the overall rate of anti-
biotic prescriptions.
In this study we examine the effect of a decision-
making aid on antibiotic stewardship in nursing
homes. This aid was created through several work-
group meetings with technical experts from the Texas
Department of Disability and Aging, nursing home
administrators, and infection control specialists; and
finalized with a usability test and a small scale trial in
several Texas nursing homes. Results of the small
scale trial can be found elsewhere [15]. The resulting
decision-making aid built directly upon current
nursing home processes, practice, and regulatory re-
quirements. It centered upon recommendations from
two clinical practice guidelines and follows the SBAR
(Situation, Background, Analysis, and Recommenda-
tion) format [http://www.ahrq.gov/professionals/educa-
tion/curriculum-tools/teamstepps/index.html]. SBAR is
designed to promote a structured conversation between
nurses and physicians to ensure that all the information
required for decision making is conveyed in an expected
order. SBAR is a standard component of the Agency for
Healthcare Research and Quality’s TeamSTEPPS® patient
safety model [2] [http://www.ahrq.gov/professionals/edu-
cation/curriculum-tools/teamstepps/index.html] [16]. The
aid focused on determining the presence or absence of
physical symptoms of a UTI based on the High and the
Loeb criteria, which are best practices model for anti-
biotic prescribing in nursing homes; and clinical prac-
tice guidelines from the Infectious Disease Society of
America, and offered alternatives to antibiotic use
when those symptoms were not present (Additional
file 1) [16].
We hypothesized that:
 The decision-making aid would be effective at
reducing antibiotic prescriptions for residents with
asymptomatic bacteuria.
 The effectiveness of the decision-making aid would
be contingent on amount of training nursing homes
received on using the aid, and resident
characteristics.
Methods
Study design
The design was a pre- and post-test with comparison
with a six month pre-intervention period and a six
month post-intervention period. Twelve nursing homes
were assigned purposively to three groups (decision-
making aid with high intensity training, decision-making
aid with low intensity training, and comparison), with
four homes per group. IRB approval has been obtained
through Texas A&M University Institutional Review
Board for human subjects (IRB number: 2009–0862).
Before inclusion all participants provided written con-
sent to participate in the study. High intensity homes re-
ceived training in using the decision making aid twice
during the intervention period, and received active tech-
nical support. Low intensity homes were trained on the
decision making aid once, and received passive technical
support only in response to requests. Low and high in-
tensity home refers to the level of training and assistance
received by nursing home residence. Active technical
support consisted of trainers asking nursing homes if
they experienced any issues with the decision making
aid. Passive technical support consisted of trainers offer-
ing assistance only if requested by the nursing home. All
training and technical support were provided by research
nurses familiar with nursing home operations. The
research nurses were further asked, at the end of the
intervention period, to assess the level of each home’s fi-
delity to the intervention and intended use of the deci-
sion making aid. Project team members also conducted
process evaluations at the end of the intervention period
with nursing home staff and administrators. Data from
the research nurses, in combination with data from the
process evaluation interviews, were used to rank the
project homes by level of fidelity to the intervention.
High fidelity homes used the decision making aid for
each instance of a suspected UTI. Low fidelity homes
rarely (less than 25 % of suspected UTI cases) used the
decision making aid. A post-hoc analysis, which grouped
the nursing homes by fidelity to the decision-making
aid, was conducted to determine whether variability in
fidelity revealed the “true” effect of the decision-making
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aid. This resulted in two groups for the post-hoc ana-
lysis– homes that actually implemented the decision-
making aid (fidelity group with four homes) and homes
that did not implement the decision-making aid (no fi-
delity group with eight homes including the four control
homes).
Data
Data were collected monthly in all 12 Texas nursing
homes for 6 months prior to introducing the decision-
making aid and for 6 months following the introduction
of the decision-making aid. The data were collected by
clinically trained nurse consultants who routinely work
with nursing homes. From March 2011 through Febru-
ary 2012, residents receiving an antibiotic for a sus-
pected UTI were identified through retrospective chart
reviews of the study homes’ infection logs, which facil-
ities are required to maintain under federal regulations
[56 FR 48876, Sept. 26, 1991, as amended at 57 FR
43925, Sept. 23, 1992]. Each of the listed UTIs were as-
sociated with an antibiotic prescription (with very few
exceptions). As a result, the infection logs essentially
represented antibiotic treatment logs. The research team
collected data on resident characteristics at admission
and information from the most recent quarterly Mini-
mum Data Set (MDS) assessments [17]. The final dataset
contained prescriptions written for suspected UTIs dur-
ing the study time period.
Measurement
Dependent variable
At the facility level, we considered the aggregate rates of
overall antibiotic prescriptions for ASB. At the prescrip-
tion level, the dependent variable was a binary variable
indicating whether an antibiotic was prescribed in the
absence of physical symptoms associated with a UTI
(yes/no) –essentially, was the prescription ordered for
asymptomatic bacteuria. These symptoms were based on
two previously published consensus criteria: the Loeb
criteria and the High criteria [2, 16]. Medical records
were reviewed to abstract any of the following signs and
symptoms from the criteria:
 acute dysuria,
 fever (>37.9 °C [100 °F]) or 1.5 °C [2.4 °F] increase
above baseline temperature),
 new or worsening urgency, frequency, or
incontinence,
 suprapubic pain,
 gross hematuria,
 costovertebral angle (flank) tenderness,
 rigors, and
 delirium (recent and abrupt change in mental
status)
Independent variables
Resident characteristics associated with each antibiotics
prescription were obtained using resident’s admission
MDS and the most recent MDS completed prior to the
date of the first suspected UTI. From this data, variables
were created to determine if resident characteristics are
associated with prescriptions for ASB. The variables in-
cluded age, race/ethnicity, gender, and urinary incontin-
ence. In addition, information on physical functioning
and communication status were used to construct vari-
ables for level of performance of activities of daily living
(an ADL hierarchy scale) [18] and the ability to verbally
communicate symptoms related to UTIs. Age was cate-
gorized into three groups (75 and younger, 76 to 85, and
86 and older). Since the vast majority of residents were
non-Hispanic whites, the race/ethnicity variable was di-
chotomized as non-Hispanic White and Other. The
model also included the variable capturing time period
(pre and post-test). The most important independent
variable is the treatment group (high-intensity, low in-
tensity, comparison). In the post-hoc analysis the model
also included a variable representing nursing home level
of fidelity to the decision-making aid.
Statistical analyses
Data were analyzed using SAS 9.2. The analyses were
intended to identify the effect of the decision-making aid
on the odds of a prescription being written for ASB after
controlling for resident characteristics.
Descriptive analyses were provided for the 12 nursing
homes and 547 residents who received antibiotic orders
for suspected UTIs during the study time period. Chi-
square tests and one way ANOVA analysis were per-
formed to test for statistically significant differences on
resident characteristics among treatment groups. Aggre-
gate rates of overall antibiotic prescriptions for ASB by
different treatment groups were also calculated. Finally,
a multivariate analysis was performed on the 669 pre-
scriptions written for 547 residents. The unit of analysis
for this multivariate modeling was the prescription. Due
to the correlated nature of the prescription data, in that
more than one prescription could be ‘nested’ within a
resident, and prescriptions from the same resident home
are also more or less “similar”, a mixed effect logistic re-
gression model was used to estimate the effects of covar-
iates on the likelihood of a prescription being written for
ASB. Thus the dependence between observations due to
‘nesting’ of prescriptions was statistically adjusted using
the GLIMMIX procedure in SAS, with nursing homes
and resident identifiers as nested random effects. The
independent variables mentioned earlier, together with
the interaction of treatment and study period (pre vs
post), were included in the model as fixed effects. The
association between each independent variable and a
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prescription being written for ASB was expressed as
odds ratio estimates with 95 % confidence intervals.
During a post-implementation process evaluation, it
became apparent that some nursing homes implemented
the tool, and some did not. There was a very stark differ-
ence in level of implementation, with homes either using
the tool for each infection noted in the infection log, or
never using the tool/using the tool for less than 25 % of
infections. For the purpose of the post-hoc analysis,
those home which implemented but never used the tool
or used the tool with less than 25 % of infections were
designated as ‘low fidelity’. The remaining homes used
the tool for each infection. This post-hoc analysis in-
cluded the entire post-intervention period.
In the post-hoc analysis, we compared aggregates rates
of prescriptions for suspected UTI for homes groups ac-
cording to fidelity (implementers vs. non-implementers)
and used the GLIMMIX procedure to fit a regression
model with fidelity as the main experimental variable. Fi-
delity to the decision making aid was determined
through process evaluations conducted at the conclusion
of the study. Of the four homes designated as having fi-
delity to the decision-making aid, three were from the
high intensity training group and one was from the low
intensity group. Of the eight homes designated as having
no fidelity to the aid, one home was from the high-
intensity group, three were from the low-intensity group,
and four were from the comparison group. A mixed ef-
fect logistic regression model was fit to the data using
similar fixed effects and random effects as in the main
analysis, except substituting treatment group (high-in-
tensity, low intensity, comparison) with the fidelity vari-
able (implementers vs. non-implementers).
Sample size consideration
The primary goal of the analysis is to compare the rate
of correct use of antibiotics in the intervention groups
with the comparison group. Power is the probability of
rejecting the null hypothesis when the null hypothesis is
wrong. In order to find the accurate measure of testing
to reject the null hypothesis the power calculation was
conducted. Based on the results (Table 1) a sample size
of 110 in each group is required when the p-value is
0.05 and we have 80 % power to reject the null
hypothesis.
Results
Home and resident characteristics
Tables 1 and 2 present data on the 12 participating nurs-
ing homes and residents who received antibiotics for a
suspected UTI in the pre-intervention period. Home
characteristics were consistent with the profile of a “typ-
ical” sample of US nursing homes, with a bed size be-
tween 78 and 120 beds, and a greater number of for-
profit ownerships. Within each group, the rate of anti-
biotic prescriptions for suspected urinary tract infections
ranged from approximately 4 to between 11 and 13 per
1,000 bed days of care. The number of active physicians
also varied considerably. Some homes had only one to
three physicians responsible for residents, while others
had more than a dozen. In general, the residents in-
cluded in the study fit the profile of the average nursing
home resident in the United States [18]. Most of the res-
idents were white, female, of older age, and experiencing
some level of urinary incontinence/cognitive impair-
ment/limitations in activities of daily living. Chi-square
tests and one-way ANOVA tests showed that the average
rate of antibiotic prescription per 1,000 resident bed
days per month and the average number of physicians
attending to patients in each home were not statistical
significantly different between homes; however the total
bed days per month, the home ownership status, and the
total bed capacities differed between homes.
Aggregate rates of antibiotic prescriptions
Table 3 provides the percentages of prescriptions written
for suspected ASB among all prescriptions for suspected
UTIs during the entire study. The majority of the
Table 1 Nursing home characteristics of 12 Texas nursing homes
Characteristic Comparison homes
(N = 4)
Lower intensity intervention
(N = 4)
Higher intensity intervention
(N = 4)
p value
For profit %(n) 75 % 100 % 75 % 0.0000
Number of attending physicians range 3 – 8 1 – 15 2 – 12
mean(SD) 5.8 (2.6) 7.0 (5.9) 5.3 (4.8) 0.0601
Average rate of antibiotic prescription per 1,000
resident bed days per month range
4.33 – 10.69 3.95 – 13.43 3.78 – 12.92
mean (SD) 1.8 (0.59) 2.2 (2.3) 2.3 (2.4) 0.2461
Total bed days per month range 1550 – 3096 1144 – 3019 1603 – 3026
mean (SD) 2133 (439) 2325 (609) 2358 (424) 0.0104
Total bed capacity range 78 – 120 88 – 120 103 – 120
mean (SD) 95 (17.8) 97(15.4) 109.3(7.8) <0.0001
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prescriptions were not associated with documented
symptoms (71 %) during the pre-intervention period.
The proportion of prescriptions for ASB increased
slightly in the comparison homes and declined in both
the low- (78 % to 65 %) and high-intensity decision-
making aid sites (65 % to 57 %) from the pre to the
post-intervention time periods. The eight homes that
did not implement the decision-making aid with any
meaningful degree of fidelity (“no-fidelity” group)
showed almost no change (70 % to 69 %) from the pre-
to the post-intervention period in the proportion of pre-
scriptions written for ASB. The proportion of
prescriptions for ASB in the four fidelity homes dropped
from 73 percent to 49 percent, a reduction of one third.
Multivariate analysis
Table 4 presents results from a mixed effect logistic re-
gression model using whether a prescription was written
for ASB as the outcome, and the original treatment as-
signment as the main covariate. Both homes and resi-
dents were initially included as random effects. However,
a likelihood ratio test indicated that a random effect for
residents was not necessary, so only home was the ran-
dom effect in the final model. The odds (from pre to
post) of a prescription being written for ASB is lower in
the low-intensity homes and in the high-intensity homes
than in the comparison homes (OR = 0.63, 95 % CI =
0.25 – 1.60 for low-intensity group; OR = 0.79, 95 % CI
= 0.33 – 1.88 for high-intensity group). However, neither
effect reaches the traditional levels required for statis-
tical significance. The only resident characteristics asso-
ciated with antibiotic prescribing were incontinence and
ability to communicate. Incontinence increased the odds
of a prescription being written in the absence of symp-
toms (OR = 1.93, 95 % CI = 1.05–3.56 for “always incon-
tinent”). A higher level of communication ability also
increased the odds of a prescription being written in the
absence of symptoms (OR = 1.26, 95 % CI = 1.00–1.59).
In the post-hoc multivariate analysis (Table 5) of fidel-
ity to treatment, results indicated that after controlling
for differences in resident characteristics, the likelihood
of a prescription being written for ASB decreased signifi-
cantly in the homes that implemented the decision-
making aid (OR = 0.35, 95 % CI = 0.16–0.76), compared
to the homes with no fidelity. Again, both incontinence
and communication ability increased the odds of a pre-
scription being written in the absence of symptoms (OR
= 1.96, 95 % CI = 1.05–3.61 for “always incontinent”; OR
= 1.26, 95 % CI = 1.00–1.60).
Discussion
When used, the decision-making aid significantly re-
duced antibiotic treatment for ASB. In the homes that
implemented the decision-making aid with fidelity, the
results indicated that the likelihood that an antibiotic
prescribed for a suspected UTI would occur without
symptoms dropped significantly in the post-intervention
period.
In a number of ways, these results go beyond those of
Loeb, Bentley, Bradley, and colleagues’ trial [2] aimed at
reducing antibiotic treatment for suspected ASB [19].
That study found that The Loeb intervention did not
significantly reduce overall antimicrobial use. It did,
however, reduce the proportion of total antimicrobials
prescribed for suspected urinary tract infection among
implementing homes. Unlike the Loeb trial, this
Table 2 Characteristics of residents with prescriptions for
suspected UTI (N = 547)
Characteristic Comparison
homes (N = 4)
Lower intensity
intervention (N = 4)
Higher intensity
intervention (N = 4)
Age
distribution
≤75% 20.39 29.41 22.40
76–85% 34.87 29.90 33.33
86+ % 44.74 40.69 44.27
Female % 74.83 76.47 75.00
White % 88.08 85.29 86.98
Urinary
incontinence %
Always
incontinent
21.85 24.02 26.04
Frequently
incontinent
27.15 18.63 23.96
Occasionally
incontinent
16.56 11.27 20.83
Never
incontinent
17.22 29.41 18.75
Not rated 17.22 16.67 10.42
Catheterized % 16.67 16.67 10.82
ADL hierarchy
(0–6) mean (SD)
2.19 (1.10) 2.38 (1.31) 2.22 (1.19)
Ability to
communicate
(0–3) mean (SD)
0.79 (0.98) 0.64 (0.89) 1.18 (0.84)
Table 3 Percentage of prescriptions for asymptomatic bacteuria
among all prescriptions in 12 Texas Nursing Home, broken
down by treatment and fidelity groups
Preintervention
[N = 355]
Postintervention
[N = 314]
Comparison homes 69.00 71.59
Low intensity homes 78.15 64.66
High intensity homes 65.44 57.27
Fidelity (post hoc) 73.15 49.35
No fidelity (post hoc) 69.64 68.78
Total 70.70 64.00
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manuscript does not comment on whether total anti-
biotic use at these facilities was affected, as data on total
use was not collected. As such, we can only discuss
changes in antibiotic use for suspected UTIs.
The researchers selected nursing homes for inclusion
in the study in a manner that created a study sample
profile consistent with a “typical” sample of U.S. nursing
homes, with a bed size between 80 and 120 beds, and a
greater number of for-profit ownerships. Each of our
three groups included homes with a variety of ownership
arrangements, though the majority in each group oper-
ated as for-profit enterprises. Even with this consistency,
the rate of antibiotic prescriptions for suspected urinary
tract infections varied greatly between groups in the pre-
implementation period, from approximately 4 to
between 11 and 13 per 1,000 bed days of care, with the
low intensity group having more prescriptions for sus-
pected ASB than the high intensity group. The number
of active physicians also varied considerably. Some
homes had only one to three physicians responsible for
residents, while others had more than a dozen. At this
point, it is unclear what factor, such as variation in resi-
dent case-mix, could explain the considerable variation
in antibiotic prescribing for ASB among the study
nursing homes. Future studies should include informa-
tion on all residents in the nursing homes, rather than
only those residents listed in the infection log (see
Recommendations).
Interpretation and application of the study findings
should take into consideration the small study sample
size (12 homes with 669 prescriptions in total), regional
differences (all the homes were in Texas), and reliance
on chart abstraction. The inherent nature of the study
design, as a quasi-experimental nonequivalent control
group design, does not control all threats to internal val-
idity. In this era of focusing on simultaneously reducing
health care costs while improving quality of care,
Table 4 Results from a mixed effect logistic regression model
on the likelihood of ASB – using original treatment assignment
as a covariate
Odds
ratio
95 % CI p
Fixed effect
High intensity training 0.77 0.32–1.86 0.57
Low intensity training 1.19 0.47–3.01 0.71
Age
≤75 vs 86+ 1.09 0.69–1.73 0.72
76–85 vs 86+ 0.96 0.64–1.44 0.86
Female 0.84 0.54–1.30 0.43
White 1.11 0.64–1.95 0.71
Urinary incontinence a
Always incontinent
vs continent
1.93 1.05–3.56 0.04
Frequently incontinent
vs continent
1.36 0.78–2.38 0.28
Occasionally incontinent
vs continent
1.16 0.65–2.09 0.61
Catheterized a 1.04 0.48–2.24 0.92
ADL hierarchy (0–6) 1.07 0.89–1.27 0.47
Ability to communicate (0–3) 1.26 1.00–1.59 0.05
Post vs Pre 0.99 0.51–1.94 0.98
Interaction between time period and training
Pre/post and high intensityb 0.79 0.33–1.88 0.59
Pre/post and low intensityb 0.63 0.25–1.60 0.33
Random Effect Variance St. Error
Home 0.2105 0.1304
aDuring the study time period the MDS 3.0 was implemented. During
implementation nursing homes were given leeway in documenting status.
This resulted in a high number of missing observations for variables such as
urinary incontinence and presence of catheter. Sensitivity analyses were
performed to determine the overall effect on the models; the models
remained robust
bThese interaction terms reflect the difference in changes from pre to post
comparing treatment groups to the control group, so they are our
main interest
Table 5 Results from a mixed effect logistic regression model
on the likelihood of ASB – using fidelity to treatment as a
covariate
Odds ratio 95 % CI P
Fixed Effect
Fidelity 1.14 0.51–2.56 0.75
Age
≤75 vs 86+ 1.09 0.69–1.73 0.74
76–85 vs 86+ 0.96 0.64–1.44 0.84
Female 0.83 0.54–1.29 0.40
White 1.13 0.64–2.00 0.67
Urinary incontinence a
Always incontinent vs continent 1.96 1.05–3.61 0.03
Frequently incontinent vs continent 1.34 0.77–2.35 0.30
Occasionally incontinent vs continent 1.13 0.63–2.03 0.69
Catheterized a 1.07 0.50–2.29 0.86
ADL hierarchy (0–6) 1.08 0.90–1.28 0.40
Ability to communicate (0–3) 1.26 1.00–1.60 0.05
Post vs Pre 1.05 0.70–1.60 0.81
Post*fidelity b 0.35 0.16–0.76 0.01
Random Effect Variance St. Error
Home 0.2110 0.1269
aDuring the study time period the MDS 3.0 was implemented. During
implementation nursing homes were given leeway in documenting status.
This resulted in a high number of missing observations for variables such as
urinary incontinence and presence of catheter. Sensitivity analyses were
performed to determine the overall effect on the models by excluding this
variable; the results remained robust
bThis interaction term reflects the difference in changes from pre to post
comparing fidelity group to the non-fidelity group, so it is our main interest
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medical chart reviews emerged as a relatively cheap (and
thus common) tool for assessing quality of health care.
While efficient, chart reviews are also potentially prob-
lematic. Chart reviews may be subject to bias based on
characteristics associated with the recorder and the pur-
pose of the chart. For example, a rushed scribe or vari-
able reimbursement rates can lead to inadvertent and
advertent (like up coding) errors. A study comparing
chart abstraction with standardized patient reports
found that chart reviews underestimated quality of care
compared to the standardized patient reports for dia-
betes, COPD, coronary artery disease, and low back pain
[20]. This underestimation was due to the standardized
patients reporting better quality of care than was noted
in the charts. While it is possible that prescribing physi-
cians did not document signs and symptoms of actual
UTIs (leading to an underestimation of appropriate pre-
scriptions), we believe our chart review data were robust.
Our findings are consistent with previous reports of
ASB in nursing homes [15]. Furthermore, in the Luck et
al. article, the majority of discrepancies between the
chart reviews and the standardized patient reports were
due to physicians charting actions that did not occur, ra-
ther than omitting information. Thus, if our chart review
data is biased, we have reason to believe it would be
biased in the direction of overestimating appropriate
antibiotic use, not underestimating appropriate anti-
biotic use. Such an instance would work to strengthen
our conclusions, not diminish.
This study also found that nursing home residents
who possess the ability to communicate were more likely
to receive an antibiotic prescription for ASB. This runs
contrary to previous literature, in which diminished
communication capacity is associated with an increased
likelihood of receiving an antibiotic under a “better safe
than sorry” rationale [21]. The MDS 3.0 was released
during the implementation phase of our study. During
that time, nurses were allowed, per CMS guidelines, a
great deal of flexibility in documenting certain condi-
tions. The flexibility gave nurses assessing residents with
the MDC 3.0 the latitude to documents items related to
these conditions as “not applicable”. One such condition
was catheterization. As a result, our data contained an
usually high number of “not applicable” responses for
the question of whether or not a resident had an in-
dwelling catheter. The high number of “not applicable”
responses is potentially related to both the ability to
communicate and whether or not a prescription is writ-
ten for ASB, as the criteria for appropriate prescribing
for residents with catheters (who are more likely to be
unable to communicate) is less stringent then the cri-
teria for residents without catheters) [22]. This may ex-
plain our results regarding communication, which
diverge from our original pilot study (in which we found
that cognitive impairment was associated with increased
likelihood of a prescription for ASB) [15].
The decision-making aid was based on a set of best
practices criteria that were formulated without a system-
atic evidence review. However, this form is intended for
nurses to use to communicate tool with the prescribing
provider, not as a diagnostic tool. Nurse communication
of signs and symptoms can play a large role in provider
prescribing practices [23] It is possible, however, that the
decision aid affected the documentation of signs and
symptoms. In this case, the decision aid led to better
documentation of appropriate cases, rather than a re-
duction of prescriptions for inappropriate cases. While
there was an overall reduction in the number of anti-
biotic prescriptions written overall between the pre
intervention and the post intervention period (a 10 % re-
duction from 355 to 314), it is impossible to determine
with the current data if this drop is due to the decision
aid or an outside factor (such as resident flow to or from
nursing homes). Likewise, it is impossible to determine
the actual drop in antibiotic prescriptions for ASB with-
out inclusion of those residents with ASB who did not
receive an antibiotic prescription. This weakens our
proposition that when used, the decision making aid re-
duced prescriptions for ASB. Future research should also
include residents who did not receive a prescription to
distinguish between improved documentation and im-
proved prescribing practices [24]. In addition, because
the sample is prescriptions and not residents, it does not
include residents who had ASB and did not receive a
prescription, nor does it include residents with the
symptoms of a UTI who did not receive a prescription.
As a result, we cannot determine the percentage of resi-
dents with ASB who receive an antibiotic prescription.
Nonetheless, the odds ratio estimates from our multi-
variate analysis provided valid estimates for the odds ra-
tios of getting a prescription for ASB comparing one
level of the covariate to the baseline level.
Conclusions
Although the decision-making aid (when used) reduced
unnecessary antibiotic use during the study, in the real
world of nursing home operations, it did not become
embedded in the everyday operations of the study nurs-
ing homes. The four homes that implemented the
decision-making aid with fidelity eventually stopped
using it. The result of the facility-level analyses is yet an-
other reminder that quality improvement interventions
face significant challenges in nursing homes. Such inter-
ventions often work as promised, but they are quickly
overwhelmed by competitive resource needs inherent in
the day-to-day operations of nursing homes · These two
findings—the success of the decision-making aid in pro-
moting appropriate antibiotic stewardship but difficulty
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in adhering to the aid—suggests that future work in this
area focus on methods to sustain the initial usage of the
decision-making aid and its impact in an environment
that does not easily adapt to new systems.
Recommendations for future studies and policies in-
clude abstracting data on all nursing home residents in
study homes, not just those residents with antibiotic pre-
scriptions or those listed in the infection logs. This will
help paint a fuller picture of prescribing practices by
allowing researchers to ascertain the conditions under
which clinicians chose not the prescribe an antibiotic.
For those interested in implementing antibiotic steward-
ship programs in nursing homes, we recommend dedi-
cating resources to ensuring uptake of any program.
When implemented, our decision making aid assisted in
improving antibiotic stewardship in the study homes.
However, homes either never fully implemented the aid
or were quick to abandon the aid post implementation.
Discussions with study nursing homes on this process
lead to a number of recommendations for enhancing up-
take and ‘stickiness’ of the aid. Those interested in
implementing antibiotic stewardship programs should
consider: identifying or developing an antibiotic steward-
ship ‘champion’ to spearhead implementation and follow
up on progress; creating protocols to prevent the pro-
gram from getting lost or forgotten when staff turnover;
charting antibiotic use to a) show that antibiotic stew-
ardship is needed, and b) show results of implementing
an antibiotic stewardship program; and educating staff,
residents, and family members on evidence-based cri-
teria for appropriate antibiotic use.
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